Herceptin: A first assault on oncogenes that launched a revolution Miscellaneous

  


Author: Sawyers, C. L.
Title: Herceptin: A first assault on oncogenes that launched a revolution
Abstract: This year's Lasker Clinical Research Award honors H. Michael Shepard, Dennis J. Slamon, and Axel Ullrich for their invention of Herceptin, the first monoclonal antibody that blocks a cancer-causing protein, and for its development as a life-saving therapy for women with breast cancer. © 2019 Elsevier Inc. This year's Lasker Clinical Research Award honors H. Michael Shepard, Dennis J. Slamon, and Axel Ullrich for their invention of Herceptin, the first monoclonal antibody that blocks a cancer-causing protein, and for its development as a life-saving therapy for women with breast cancer. © 2019 Elsevier Inc.
Journal Title: Cell
Volume: 179
Issue: 1
ISSN: 0092-8674
Publisher: Cell Press  
Date Published: 2019-09-19
Start Page: 8
End Page: 12
Language: English
DOI: 10.1016/j.cell.2019.08.027
PUBMED: 31519311
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072226305&doi=10.1016%2fj.cell.2019.08.027&partnerID=40&md5=1b8fae5b5490a54ff0f326ad19186139
Notes: Short Survey -- Export Date: 1 October 2019 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Charles L Sawyers
    225 Sawyers
Related MSK Work